Register
Login:
Share:
Email Facebook Twitter




Physiomics Share Chat (PYC)



Share Price: 0.035Bid: 0.03Ask: 0.04Change: 0.00 (0.00%)No Movement on Physiomics
Spread: 0.01Spread as %: 33.33%Open: 0.035High: 0.035Low: 0.035Yesterday’s Close: 0.035


Share Discussion for Physiomics


Thread View

Please login or register to post a message on Share Chat.

Posts per page:

Hondadave
Posts: 3,520
Off Topic
Opinion:No Opinion
Price:0.0375
Pyc
Thu 11:41
As predictable as ever!!
 
Hondadave
Posts: 3,520
Off Topic
Opinion:No Opinion
Price:0.035
News?
Wed 13:10
Lol
Hawkander
Posts: 296
Off Topic
Opinion:No Opinion
Price:0.0325
VAL & SAR
Wed 11:38
nice rises for both, so should be positive news here soon.
estar98
Posts: 12
Off Topic
Opinion:No Opinion
Price:0.0325
PYC should rush to China
Tue 21:34
If the directors are really interested in promoting the services and technology for personalised medication, they should start to look for opportunities in China market. they should find a good china market consultant to carry out the jobs for them as they are proving hopeless over the years in terms of promoting the PYC technology platforms and unique services. although they signed up certain clients including major global pharmaceutical companies but the clients base and usage volume should be much wider and higher.
estar98
Posts: 12
Off Topic
Opinion:No Opinion
Price:0.0325
China $9 Billion Precision Medicine
Tue 21:27
China is expected to soon announce a massive investment in precision medicine, with plans to spend $9 billion over the next fifteen years. The effort will combine genomic sequencing and clinical patient data to tailor medical treatments to individuals, with the goal of improving care and curtailing waste. China's investment dwarfs a similar US initiative. One year ago, the US announced a $215 million plan, run by the National Institutes of Health, though that effort was spread over just four years. Some of China's money will be allocated to develop new drugs, based on research discoveries. - See more at: http://www.chinabiotoday.com/articles/20160202#sthash.KLMzRyyH.dpuf
Hawkander
Posts: 296
Off Topic
Opinion:No Opinion
Price:0.0325
News?
Tue 13:05
With VAL and SAR on the rise now, surely we should have some news here soon and hopefully a decent rise?
Hondadave
Posts: 3,520
Off Topic
Opinion:No Opinion
Price:0.0325
Drop
Tue 09:37
Because they are slowly running the company into the ground taking our invested money with them!
bigeye54
Posts: 75
Off Topic
Opinion:No Opinion
Price:0.0325
Share drop
Mon 16:25
Why does this share drop when buys outweigh the sells all the time? What am I missing?
Utahsaints
Posts: 484
Off Topic
Opinion:No Opinion
Price:0.0375
Obelix
5 Feb '16
Let's just recap for everyone there will be rns for sar pyc and val next week?
Obelix
Posts: 9,009
Off Topic
Opinion:No Opinion
Price:0.0375
RE: Obelix
4 Feb '16
Hi Draey, good to see you're back here. SAR looks good, but VAL (the mm's) are playing very well the game there.
Also, YA Global is killing the share price & performance.
Here, We know already, no news, lack of communication from our BOD sink your price. I wonder what's they done or they will do with £990k from last Year.
Have a good day out there Mate, take care.
Obelix




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.